| Product Code: ETC6748578 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Next Generation Cancer Diagnostics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Next Generation Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 China Next Generation Cancer Diagnostics Market - Industry Life Cycle |
3.4 China Next Generation Cancer Diagnostics Market - Porter's Five Forces |
3.5 China Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 China Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Cancer, 2021 & 2031F |
3.8 China Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Function, 2021 & 2031F |
4 China Next Generation Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Rising healthcare expenditure in the country |
4.2.3 Government initiatives to improve cancer diagnosis and treatment |
4.2.4 Technological advancements in cancer diagnostics |
4.2.5 Growing awareness about early cancer detection |
4.3 Market Restraints |
4.3.1 Limited access to advanced diagnostic technologies in remote areas |
4.3.2 High cost associated with next-generation cancer diagnostics |
4.3.3 Stringent regulatory requirements for product approval |
4.3.4 Lack of skilled healthcare professionals for interpreting diagnostic results |
5 China Next Generation Cancer Diagnostics Market Trends |
6 China Next Generation Cancer Diagnostics Market, By Types |
6.1 China Next Generation Cancer Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Next-generation Sequencing, 2021- 2031F |
6.1.4 China Next Generation Cancer Diagnostics Market Revenues & Volume, By qPCR & Multiplexing, 2021- 2031F |
6.1.5 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), 2021- 2031F |
6.1.6 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Protein Microarrays, 2021- 2031F |
6.1.7 China Next Generation Cancer Diagnostics Market Revenues & Volume, By DNA Microarrays, 2021- 2031F |
6.2 China Next Generation Cancer Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Biomarker Development, 2021- 2031F |
6.2.3 China Next Generation Cancer Diagnostics Market Revenues & Volume, By CTC Analysis, 2021- 2031F |
6.2.4 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Proteomic Analysis, 2021- 2031F |
6.2.5 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Epigenetic Analysis, 2021- 2031F |
6.2.6 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Genetic Analysis, 2021- 2031F |
6.3 China Next Generation Cancer Diagnostics Market, By Cancer |
6.3.1 Overview and Analysis |
6.3.2 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.3.3 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.3.4 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.3.5 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.3.6 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Next Generation Cancer Diagnostics Market, By Function |
6.4.1 Overview and Analysis |
6.4.2 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Therapeutic Monitoring, 2021- 2031F |
6.4.3 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.4.4 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Prognostics, 2021- 2031F |
6.4.5 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Cancer Screening, 2021- 2031F |
6.4.6 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Risk Analysis, 2021- 2031F |
7 China Next Generation Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 China Next Generation Cancer Diagnostics Market Export to Major Countries |
7.2 China Next Generation Cancer Diagnostics Market Imports from Major Countries |
8 China Next Generation Cancer Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of next-generation cancer diagnostic technologies in China |
8.2 Number of research and development collaborations for innovative cancer diagnostic solutions |
8.3 Patient outcomes and survival rates post-implementation of advanced diagnostic techniques |
9 China Next Generation Cancer Diagnostics Market - Opportunity Assessment |
9.1 China Next Generation Cancer Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 China Next Generation Cancer Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Next Generation Cancer Diagnostics Market Opportunity Assessment, By Cancer, 2021 & 2031F |
9.4 China Next Generation Cancer Diagnostics Market Opportunity Assessment, By Function, 2021 & 2031F |
10 China Next Generation Cancer Diagnostics Market - Competitive Landscape |
10.1 China Next Generation Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 China Next Generation Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here